Bristol Myers Squibb (CELG-RI) Prepaid Assets (2009 - 2026)

Bristol Myers Squibb (CELG-RI) reported Prepaid Assets of $4.6 billion for Q1 2026, down 16.93% year-over-year from $5.5 billion in Q1 2025, and little changed quarter-over-quarter from $4.6 billion in Q4 2025.

Bristol Myers Squibb (CELG-RI) Prepaid Assets (2009 - 2026) Analysis & Trends

Bristol Myers Squibb (CELG-RI) has 18 years of Prepaid Assets data on file, last reported at $4.6 billion in Q1 2026.

  • Prepaid Assets for Q1 2026 came in at $4.6 billion, down 16.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.6 billion (down 16.93% YoY), and the FY2025 annual result was $4.6 billion, down 17.87% from the prior year.
  • Prepaid Assets held at $4.6 billion in Q1 2026 per CELG-RI's latest filing, from $4.6 billion in the prior quarter.
  • Over five years, Prepaid Assets peaked at $7.2 billion in Q3 2023 and troughed at $4.5 billion in Q1 2022.
  • A 5-year average of $5.6 billion and a median of $5.6 billion in 2024 frame the typical range for Prepaid Assets.
  • The sharpest annual moves came in 2022 and 2024: Prepaid Assets soared 39.11% in 2022, then fell 21.98% in 2024.
  • A 5-year view of Prepaid Assets shows it stood at $5.8 billion in 2022, then increased by 1.93% to $5.9 billion in 2023, then retreated by 4.91% to $5.6 billion in 2024, then slipped by 17.87% to $4.6 billion in 2025, then dropped by 0.35% to $4.6 billion in 2026.
  • Business Quant data shows CELG-RI's Prepaid Assets at $4.6 billion in Q1 2026, $4.6 billion in Q4 2025, and $4.9 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Bristol Myers Squibb - - 8.07 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.60 Bn
Dec 31, 2025 4.61 Bn
Sep 30, 2025 4.95 Bn
Jun 30, 2025 5.47 Bn
Mar 31, 2025 5.53 Bn
Dec 31, 2024 5.62 Bn
Sep 30, 2024 5.62 Bn
Jun 30, 2024 5.74 Bn
Mar 31, 2024 5.57 Bn
Dec 31, 2023 5.91 Bn
Sep 30, 2023 7.21 Bn
Jun 30, 2023 6.87 Bn
Mar 31, 2023 5.16 Bn
Dec 31, 2022 5.80 Bn
Sep 30, 2022 6.08 Bn
Jun 30, 2022 5.76 Bn
Mar 31, 2022 4.54 Bn
Dec 31, 2021 4.83 Bn
Sep 30, 2021 4.37 Bn
Jun 30, 2021 5.04 Bn